Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Mark Lovell to Oxidation-Reduction

This is a "connection" page, showing publications Mark Lovell has written about Oxidation-Reduction.

 
Connection Strength
 
 
 
0.826
 
  1. Lovell MA, Markesbery WR. Oxidative damage in mild cognitive impairment and early Alzheimer's disease. J Neurosci Res. 2007 Nov 01; 85(14):3036-40.
    View in: PubMed
    Score: 0.233
  2. Bradley-Whitman MA, Timmons MD, Beckett TL, Murphy MP, Lynn BC, Lovell MA. Nucleic acid oxidation: an early feature of Alzheimer's disease. J Neurochem. 2014 Jan; 128(2):294-304.
    View in: PubMed
    Score: 0.088
  3. Lovell MA, Soman S, Bradley MA. Oxidatively modified nucleic acids in preclinical Alzheimer's disease (PCAD) brain. Mech Ageing Dev. 2011 Aug; 132(8-9):443-8.
    View in: PubMed
    Score: 0.076
  4. Lovell MA, Xiong S, Lyubartseva G, Markesbery WR. Organoselenium (Sel-Plex diet) decreases amyloid burden and RNA and DNA oxidative damage in APP/PS1 mice. Free Radic Biol Med. 2009 Jun 01; 46(11):1527-33.
    View in: PubMed
    Score: 0.064
  5. Lovell MA, Markesbery WR. Oxidative DNA damage in mild cognitive impairment and late-stage Alzheimer's disease. Nucleic Acids Res. 2007; 35(22):7497-504.
    View in: PubMed
    Score: 0.058
  6. Lovell MA, Markesbery WR. Oxidatively modified RNA in mild cognitive impairment. Neurobiol Dis. 2008 Feb; 29(2):169-75.
    View in: PubMed
    Score: 0.058
  7. Markesbery WR, Lovell MA. DNA oxidation in Alzheimer's disease. Antioxid Redox Signal. 2006 Nov-Dec; 8(11-12):2039-45.
    View in: PubMed
    Score: 0.054
  8. Wang J, Xiong S, Xie C, Markesbery WR, Lovell MA. Increased oxidative damage in nuclear and mitochondrial DNA in Alzheimer's disease. J Neurochem. 2005 May; 93(4):953-62.
    View in: PubMed
    Score: 0.049
  9. Xie C, Markesbery WR, Lovell MA. Survival of hippocampal and cortical neurons in a mixture of MEM+ and B27-supplemented neurobasal medium. Free Radic Biol Med. 2000 Mar 01; 28(5):665-72.
    View in: PubMed
    Score: 0.034
  10. Lovell MA, Xie C, Markesbery WR. Decreased base excision repair and increased helicase activity in Alzheimer's disease brain. Brain Res. 2000 Feb 07; 855(1):116-23.
    View in: PubMed
    Score: 0.034
  11. Lovell MA, Gabbita SP, Markesbery WR. Increased DNA oxidation and decreased levels of repair products in Alzheimer's disease ventricular CSF. J Neurochem. 1999 Feb; 72(2):771-6.
    View in: PubMed
    Score: 0.032
  12. Weidner AM, Bradley MA, Beckett TL, Niedowicz DM, Dowling AL, Matveev SV, LeVine H, Lovell MA, Murphy MP. RNA oxidation adducts 8-OHG and 8-OHA change with A?42 levels in late-stage Alzheimer's disease. PLoS One. 2011; 6(9):e24930.
    View in: PubMed
    Score: 0.019
  13. Sullivan PG, Rabchevsky AG, Keller JN, Lovell M, Sodhi A, Hart RP, Scheff SW. Intrinsic differences in brain and spinal cord mitochondria: Implication for therapeutic interventions. J Comp Neurol. 2004 Jul 05; 474(4):524-34.
    View in: PubMed
    Score: 0.012
  14. Xie C, Lovell MA, Markesbery WR. Glutathione transferase protects neuronal cultures against four hydroxynonenal toxicity. Free Radic Biol Med. 1998 Nov 15; 25(8):979-88.
    View in: PubMed
    Score: 0.008
  15. Gabbita SP, Lovell MA, Markesbery WR. Increased nuclear DNA oxidation in the brain in Alzheimer's disease. J Neurochem. 1998 Nov; 71(5):2034-40.
    View in: PubMed
    Score: 0.008
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)